This month, the World Health Organization released new guidelines on the ethics and governance of LLMs in healthcare. Reactions from the leaders of healthcare AI companies have been mainly positive. However, one leader pointed out that fear or the risks associated with LLMs shouldn't hinder innovation, and another noted that the guidance may have failed to mention a major topic.
According to a news report, the decision comes after French health authorities warned against the drug's use. Meanwhile, the WHO suspended clinical testing of the drug after a paper in The Lancet raised concerns over safety and lack of efficacy.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Merck's investigational Ebola-Zaire vaccine protected 100 percent of patients enrolled in a creative study design, according to data published in The Lancet on Thursday. Efforts to stockpile the drug are already underway.
The World Health Organization is clarifying the dos and don'ts of how we name emerging diseases.
Michael Weinstein, the president of the Los Angeles-based AIDS Healthcare Foundation is not necessarily who you’d expect to be standing up against Truvada – the medication created to prevent H.I.V. Truvada is used as pre-exposure prophylaxis, or PrEP. Weinsteing has called it “a public health disaster in the making.” Starting this week, the AIDS Healthcare Foundation […]